Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Longley

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2012
Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancerLeanne Stevenson, Wendy L Allen, Richard Turkington, et al.
Nanoscale|October 19, 2019
Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumoursWilliam J McDaid, Michelle K Greene, Michael C Johnston, et al.
Cell Death Discovery|July 28, 2020
Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancerJennifer Ferris, Margarita Espona-Fiedler, Claudia Hamilton, et al.
British Journal of Haematology|November 22, 2012
Prognostic and therapeutic relevance of c-FLIP in acute myeloid leukaemiaDonal McLornan, Jodie Hay, Kirsty McLaughlin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2014
Efficient drug delivery and induction of apoptosis in colorectal tumors using a death receptor 5-targeted nanomedicineDaniela Schmid, Francois Fay, Donna M Small, et al.
Cell Death & Disease|December 1, 2020
Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic BirinapantMichael Fichtner, Emir Bozkurt, Manuela Salvucci, et al.
Biomacromolecules|January 19, 2013
Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticlesSharif M Abdelghany, Daniela Schmid, Jill Deacon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Clinical determinants of response to irinotecan-based therapy derived from cell line modelsWendy L Allen, Vicky M Coyle, Puthen V Jithesh, et al.
Nanoscale|May 22, 2020
Refined construction of antibody-targeted nanoparticles leads to superior antigen binding and enhanced delivery of an entrapped payload to pancreatic cancer cellsMichelle K Greene, João C F Nogueira, Shannon R Tracey, et al.
Nanoscale|December 20, 2018
Development of an advanced nanoformulation for the intracellular delivery of a caspase-3 selective activity-based probeFrancesco Cogo, Marcin Poreba, Wioletta Rut, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2012
Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancerLeanne Stevenson, Wendy L Allen, Richard Turkington, et al.
Nanoscale|October 19, 2019
Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumoursWilliam J McDaid, Michelle K Greene, Michael C Johnston, et al.
Cell Death Discovery|July 28, 2020
Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancerJennifer Ferris, Margarita Espona-Fiedler, Claudia Hamilton, et al.
British Journal of Haematology|November 22, 2012
Prognostic and therapeutic relevance of c-FLIP in acute myeloid leukaemiaDonal McLornan, Jodie Hay, Kirsty McLaughlin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2014
Efficient drug delivery and induction of apoptosis in colorectal tumors using a death receptor 5-targeted nanomedicineDaniela Schmid, Francois Fay, Donna M Small, et al.
Cell Death & Disease|December 1, 2020
Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic BirinapantMichael Fichtner, Emir Bozkurt, Manuela Salvucci, et al.
Biomacromolecules|January 19, 2013
Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticlesSharif M Abdelghany, Daniela Schmid, Jill Deacon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Clinical determinants of response to irinotecan-based therapy derived from cell line modelsWendy L Allen, Vicky M Coyle, Puthen V Jithesh, et al.
Nanoscale|May 22, 2020
Refined construction of antibody-targeted nanoparticles leads to superior antigen binding and enhanced delivery of an entrapped payload to pancreatic cancer cellsMichelle K Greene, João C F Nogueira, Shannon R Tracey, et al.
Nanoscale|December 20, 2018
Development of an advanced nanoformulation for the intracellular delivery of a caspase-3 selective activity-based probeFrancesco Cogo, Marcin Poreba, Wioletta Rut, et al.
Pageof 12